Pathological role of tonsillar B cells in IgA nephropathy

Clinical and Developmental Immunology

Volumn 2011, Issue , 2011, Pages

  Suzuki, Yusuke ^a   Suzuki, Hitoshi ^a   Nakata, Junichiro ^a   Sato, Daisuke ^a   Kajiyama, Tadahiro ^a   Watanabe, Tomonari ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; CD19 ANTIBODY; FOOD ANTIGEN; GALACTOSE DEFICIENT IMMUNOGLOBULIN A1; GLIADIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN A2; NEPHRITOGENIC ANTIGEN; OVALBUMIN; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; STEROID; TOLL LIKE RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; BONE MARROW; BONE MARROW TRANSPLANTATION; EXPERIMENTAL STUDY; HEMATURIA; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; KIDNEY BIOPSY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TONSIL CELL; WILD TYPE; ANIMAL; BONE MARROW CELL; CHEMISTRY; DISEASE MODEL; GLYCOSYLATION; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; MUCOSA; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECRETION; TONSILLITIS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; B-LYMPHOCYTES; BONE MARROW CELLS; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; MICE; MICE, SCID; MUCOUS MEMBRANE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEROIDS; TOLL-LIKE RECEPTORS; TONSILLITIS;

EID: 80052772773     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2011/639074     Document Type: Review

References (99)

1. Strippoli G. F. M., Maione A., Schena F. P., Tognoni G., Craig J. C., IgA nephropathy: a disease in search of a large-scale clinical trial to reliably inform practice American Journal of Kidney Diseases 2009 53 1 5 8
2. Barratt J., Feehally J., IgA nephropathy Journal of the American Society of Nephrology 2005 16 7 2088 2097 (Pubitemid 41716440)
3. Floege J., Burg M., Kliem V., Recurrent IgA nephropathy after kidney transplantation: not a benign condition Nephrology Dialysis Transplantation 1998 13 8 1933 1935 (Pubitemid 28356754)
4. Cuevas X., Lloveras J., Mir M., Aubia J., Masramon J., Disappearance of mesangial IgA deposits from the kidneys of two donors after transplantation Transplantation Proceedings 1987 19 1 2208 2209
5. Sanfilippo F., Croker B. P., Bollinger R. R., Fate of four cadaveric donor renal allografts with mesangial IgA deposits Transplantation 1982 33 4 370 376 (Pubitemid 12156937)
6. Suzuki Y., Tomino Y., Potential immunopathogenic role of the mucosa-bone marrow axis in IgA nephropathy: insights from animal models Seminars in Nephrology 2008 28 1 66 77
7. Barratt J., Feehally J., Smith A. C., Pathogenesis of IgA nephropathy Seminars in Nephrology 2004 24 3 197 217 (Pubitemid 38685990)
8. Emancipator S. N., Immunoregulatory factors in the pathogenesis of IgA nephropathy Kidney International 1990 38 6 1216 1229
9. de Fijter J. W., Eijgenraam J. W., Braam C. A., Holmgren J., Daha M. R., Van Es L. A., Van Den Wall Bake A. W. L., Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nepbropathy Kidney International 1996 50 3 952 961 (Pubitemid 26302685)
10. Roodnat J. I., de Fijter J. W., van Kooten C., Daha M. R., Van Es L. A., Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy Nephrology Dialysis Transplantation 1999 14 2 353 359 (Pubitemid 29062790)
11. Xie Y., Nishi S., Ueno M., Imai N., Sakatsume M., Narita I., Suzuki Y., Akazawa K., Shimada H., Arakawa M., Gejyo F., The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy Kidney International 2003 63 5 1861 1867 (Pubitemid 36513334)
12. Sato M., Hotta O., Tomioka S., Horigome I., Chiba S., Miyazaki M., Noshiro H., Taguma Y., Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy Nephron Clinical Practice 2003 93 4 137 145
13. Hotta O., Miyazaki M., Furuta T., Tomioka S., Chiba S., Horigome I., Abe K., Taguma Y., Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy American Journal of Kidney Diseases 2001 38 4 736 743
14. Komatsu H., Fujimoto S., Hara S., Sato Y., Yamada K., Kitamura K., Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study Clinical Journal of the American Society of Nephrology 2008 3 5 1301 1307
15. Rasche F. M., Schwarz A., Keller F., Tonsillectomy does not prevent a progressive course in IgA nephropathy Clinical Nephrology 1999 51 3 147 152 (Pubitemid 29116416)
16. Piccoli A., Codognotto M., Tabbi M. G., Favaro E., Rossi B., Influence of tonsillectomy on the progression of mesangioproliferative glomerulonephritis Nephrology Dialysis Transplantation 2010 25 8 2583 2589
17. Chen Y., Tang Z., Wang Q., Yu Y., Zeng C., Chen H., Liu Z. H., Li L. S., Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy American Journal of Nephrology 2007 27 2 170 175 (Pubitemid 46588183)
18. Ibels L. S., Gyory A. Z., Caterson R. J., Pollock C. A., Mahony J. F., Waugh D. A., Coulshed S., Recognition and management of IgA nephropathy Drugs 1998 55 1 73 83
19. Miura N., Imai H., Kikuchi S., Hayashi S., Endoh M., Kawamura T., Tomino Y., Moriwaki K., Kiyomoto H., Kohagura K., Nakazawa E., Kusano E., Mochizuki T., Nomura S., Sasaki T., Kashihara N., Soma J., Tomo T., Nakabayashi I., Yoshida M., Watanabe T., Tonsillectomy and steroid pulse (TSP) therapy for patients with IgA nephropathy: a nationwide survey of TSP therapy in Japan and an analysis of the predictive factors for resistance to TSP therapy Clinical and Experimental Nephrology 2009 13 5 460 466
20. Kataura A., Tsubota H., Clinical analyses of focus tonsil and related diseases in Japan Acta Oto-Laryngologica 1996 523, supplement 161 164 (Pubitemid 26130574)
21. Ono T., Jono M., Kito M., Evaluation of tonsillectomy as a treatment for pustulosis palmaris et plantaris Acta Oto-Laryngologica 1983 401 12 16 (Pubitemid 14211919)
22. Yokoyama M., Hashiguchi K., Yamasaki Y., Effects of tonsillectomy in patients with pusutulosis Palmaris et plantaris Acta Oto-Laryngologica 2004 124 1109 1110 (Pubitemid 39524761)
23. Noda K., Kodama S., Suenaga S., Suzuki M., Tonsillar focal infectious disease involving IgA nephropathy, pustulosis, and ossification Clinical and Experimental Nephrology 2007 11 1 97 101 (Pubitemid 46474963)
24. Tomino Y., Endoh M., Nomoto Y., Sakai H., Immunoglobulin A1 and IgA nephropathy New England Journal of Medicine 1981 305 19 1159 1160
25. van den Wall Bake A. W. L., Evers-Schouten J., van Es L. A., Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropathy: evidence for the bone marrow as the source of mesangial IgA American Journal of Kidney Diseases 1988 12 5 410 414
26. Sakai O., IgA nephropathy: current concepts and feature trends Nephrology 1997 3 2 3
27. Iwata Y., Wada T., Uchiyama A., Miwa A., Nakaya I., Tohyama T., Yamada Y., Kurokawa T., Yoshida T., Ohta S., Yokoyama H., Iida H., Remission of IgA nephropathy after allogeneic peripheral blood stem cell transplantation followed by immunosuppression for acute lymphocytic leukemia Internal Medicine 2006 45 22 1291 1295 (Pubitemid 44942087)
28. Layward L., Finnemore A. M., Allen A. C., Harper S. J., Feehally J., Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy Clinical Immunology and Immunopathology 1993 69 3 306 313 (Pubitemid 24009272)
29. van den Wall Bake A. W., Beyer W. E., Evers-Schouten J. H., Hermans J., Daha M. R., Masurel N., Van Es L. A., Humoral immune response to influenza vaccination in patients with primary immunoglobulin A nephropathy. An analysis of isotype distribution and size of the influenza-specific antibodies Journal of Clinical Investigation 1989 84 4 1070 1075 (Pubitemid 19247575)
30. Bene M. C., Faure G., de Ligny B. H., Immunoglobulin A nephropathy. Quantitative immunohistomorphometry of the tonsillar plasma cells evidences an inversion of the immunoglobulin A versus immunoglobulin G secreting cell balance Journal of Clinical Investigation 1983 71 5 1342 1347 (Pubitemid 13098923)
31. Harper S. J., Feehally J., The pathogenic role of immunoglobulin A polymers in immunoglobulin A nephropathy Nephron 1993 65 3 337 345 (Pubitemid 23321227)
32. Kusakari C., Nose M., Takasaka T., Yuasa R., Kato M., Miyazono K., Fujita T., Kyogoku M., Immunopathological features of palatine tonsil characteristic of IgA nephropathy: IgA1 localization in follicular dendritic cells Clinical and Experimental Immunology 1994 95 1 42 48 (Pubitemid 24207101)
33. Harper S. J., Pringle J. H., Wicks A. C. B., Hattersley J., Layward L., Allen A., Gillies A., Lauder I., Feehally J., Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy Kidney International 1994 45 3 836 844 (Pubitemid 24094497)
34. van den Wall Bake A. W., Daha M. R., van Es L. A., Immunopathogenetic aspects of IgA nephropathy Nephrologie 1989 10 3 141 145 (Pubitemid 20047868)
35. van Es L. A., van den Wall Bake A. W., Stad R. K., van den Dobbelsteen M. E., Bogers M. J., Daha M. R., Enigmas in the pathogenesis of IgA nephropathy Contributions to Nephrology 1995 111 169 175
36. Kunkel E. J., Butcher E. C., Plasma-cell homing Nature Reviews Immunology 2003 3 10 822 829 (Pubitemid 37328660)
37. Moldoveanu Z., Wyatt R. J., Lee J. Y., Tomana M., Julian B. A., Mestecky J., Huang W. Q., Anreddy S. R., Hall S., Hastings M. C., Lau K. K., Cook W. J., Novak J., Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels Kidney International 2007 71 11 1148 1154 (Pubitemid 46809135)
38. Suzuki H., Moldoveanu Z., Hall S., Brown R., Vu H. L., Novak L., Julian B. A., Tomana M., Wyatt R. J., Edberg J. C., Alarcn G. S., Kimberly R. P., Tomino Y., Mestecky J., Novak J., IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1 Journal of Clinical Investigation 2008 118 2 629 639 (Pubitemid 351206552)
39. Glassock R. J., Analyzing antibody activity in IgA nephropathy Journal of Clinical Investigation 2009 119 6 1450 1452
40. Hiki Y., Odani H., Takahashi M., Yasuda Y., Nishimoto A., Iwase H., Shinzato T., Kobayashi Y., Maeda K., Mass spectrometry proves under- O -glycosylation of glomerular IgA1 in IgA nephropathy Kidney International 2001 59 3 1077 1085 (Pubitemid 32206870)
41. Allen A. C., Bailey E. M., Brenchley P. E. C., Buck K. S., Barratt J., Feehally J., Mesangial Iga1 in IgA nephropathy exhibits aberrant O -glycosylation: observations in three patients Kidney International 2001 60 3 969 973 (Pubitemid 34205796)
42. Kokubo T., Hiki Y., Iwase H., Tanaka A., Toma K., Hotta K., Kobayashi Y., Protective role of IgA1 glycans against IgA1 self- aggregation and adhesion to extracellular matrix proteins Journal of the American Society of Nephrology 1998 9 11 2048 2054 (Pubitemid 28482152)
43. Novak J., Julian B. A., Tomana M., Mestecky J., IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy Seminars in Nephrology 2008 28 1 78 87
44. Hiki Y., O -linked oligosaccharides of the IgA1 hinge region: roles of its aberrant structure in the occurrence and/or progression of IgA nephropathy Clinical and Experimental Nephrology 2009 13 5 415 423
45. Novak J., Tomana M., Matousovic K., Brown R., Hall S., Novak L., Julian B. A., Wyatt R. J., Mestecky J., IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells Kidney International 2005 67 2 504 513 (Pubitemid 40139842)
46. Novak J., Vu H. L., Novak L., Julian B. A., Mestecky J., Tomana M., Interactions of human mesangial cells with IgA and IgA-containing immune complexes Kidney International 2002 62 2 465 475 (Pubitemid 34779757)
47. Gmez-Guerrero C., Gonzlez E., Egido J., Evidence for a specific IgA receptor in rat and human mesangial cells Journal of Immunology 1993 151 12 7172 7181 (Pubitemid 24001091)
48. Gmez-Guerrero C., Lpez-Armada M. J., Gonzlez E., Egido J., Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF- and IL-6, and proliferation Journal of Immunology 1994 153 11 5247 5256 (Pubitemid 24356157)
49. van der Boog P. J. M., van Kooten C., de Fijter J. W., Daha M. R., Role of macromolecular IgA in IgA nephropathy Kidney International 2005 67 3 813 821 (Pubitemid 41623306)
50. Mestecky J., Tomana M., Crowley-Nowick P. A., Moldoveanu Z., Julian B. A., Jackson S., Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy Contributions to Nephrology 1993 104 172 182
51. Coppo R., Amore A., Aberrant glycosylation in IgA nephropathy (IgAN) Kidney International 2004 65 5 1544 1547 (Pubitemid 38590997)
52. Horie A., Hiki Y., Odani H., Yasuda Y., Takahashi M., Kato M., Iwase H., Kobayashi Y., Nakashima I., Maeda K., IgA1 molecules produced by tonsillar lymphocytes are under- O -glycosylated in IgA nephropathy American Journal of Kidney Diseases 2003 42 3 486 496 (Pubitemid 37048124)
53. Itoh A., Iwase H., Takatani T., Nakamura I., Hayashi M., Oba K., Hiki Y., Kobayashi Y., Okamoto M., Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients Nephrology Dialysis Transplantation 2003 18 6 1108 1114 (Pubitemid 36722511)
54. Iwanami N., Iwase H., Takahashi N., Kato K., Itoh A., Takatani T., Makita S., Kobayashi Y., Okamoto M., Nakamura S., Hiki Y., Ishii M., Similarities between N -glycan glycoform of tonsillar IgA1 and that of aberrant IgA1 abundant in IgA nephropathy patient serum Journal of Nephrology 2008 21 1 118 126 (Pubitemid 351780581)
55. Inoue T., Sugiyama H., Hiki Y., Takiue K., Morinaga H., Kitagawa M., Maeshima Y., Fukushima K., Nishizaki K., Akagi H., Narimatsu Y., Narimatsu H., Makino H., Differential expression of glycogenes in tonsillar B lymphocytes in association with proteinuria and renal dysfunction in IgA nephropathy Clinical Immunology 2010 136 3 447 455
56. Monteiro R. C., Van De Winkel J. G. J., IgA Fc receptors Annual Review of Immunology 2003 21 177 204 (Pubitemid 37174530)
57. Nishie T., Miyaishi O., Azuma H., Kameyama A., Naruse C., Hashimoto N., Yokoyama H., Narimatsu H., Wada T., Asano M., Development of immunoglobulin A nephropathy-like disease in -1,4-galactosyltransferase-I-deficient mice American Journal of Pathology 2007 170 2 447 456 (Pubitemid 47339382)
58. Kobayashi I., Nogaki F., Kusano H., Ono T., Miyawaki S., Yoshida H., Muso E., Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels Nephrology Dialysis Transplantation 2002 17 12 2108 2116 (Pubitemid 35446665)
59. Glassock R. J., IgA nephropathy: challenges and opportunities Cleveland Clinic Journal of Medicine 2008 75 8 569 576
60. Gharavi A. G., Moldoveanu Z., Wyatt R. J., Barker C. V., Woodford S. Y., Lifton R. P., Mestecky J., Novak J., Julian B. A., Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy Journal of the American Society of Nephrology 2008 19 5 1008 1014
61. Suzuki H., Fan R., Zhang Z., Brown R., Hall S., Julian B. A., Chatham W. W., Suzuki Y., Wyatt R. J., Moldoveanu Z., Lee J. Y., Robinson J., Tomana M., Tomino Y., Mestecky J., Novak J., Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity Journal of Clinical Investigation 2009 119 6 1668 1677
62. Barratt J., Eitner F., Feehally J., Floege J., Immune complex formation in IgA nephropathy: a case of the right antibodies in the wrong place at the wrong time Nephrology Dialysis Transplantation 2009 24 12 3620 3623
63. Barratt J., Eitner F., Glomerular disease: sugars and immune complex formation in IgA nephropathy Nature Reviews Nephrology 2009 5 612 614
64. Suzuki H., Suzuki Y., Aizawa M., Yamanaka T., Kihara M., Pang H., Horikoshi S., Tomino Y., Th1 polarization in murine IgA nephropathy directed by bone marrow-derived cells Kidney International 2007 72 3 319 327 (Pubitemid 47172373)
65. Leinikki P. O., Mustonen J., Pasternack A., Immune response to oral polio vaccine in patients with IgA glomerulonephritis Clinical and Experimental Immunology 1987 68 1 33 38 (Pubitemid 17044774)
66. Emancipator S. N., Gallo G. R., Lamm M. E., Experimental IgA nephropathy induced by oral immunization Journal of Experimental Medicine 1983 157 2 572 582 (Pubitemid 13145060)
67. Coppo R., Basolo B., Rollino C., Mediterranean diet and primary IgA nephropathy Clinical Nephrology 1986 26 2 72 82 (Pubitemid 16039419)
68. Kumar V., Sieniawska M., Beutner E. H., Chorzelski T. P., Are immunological markers of gluten-sensitive enteropathy detectable in IgA nephropathy? The Lancet 1988 2 8623 1307
69. Fornasieri A., Sinico R. A., Maldifassi P., IgA-Antigliadin antibodies in IgA mesangial nephropathy (Berger's disease) British Medical Journal 1987 295 6590 78 80 (Pubitemid 17096077)
70. Rostoker G., Laurent J., André C., Cholin S., Lagrue G., High levels of IgA antigliadin antibodies in patients who have IgA mesangial glomerulonephritis but not coeliac disease The Lancet 1988 1 8581 356 357 (Pubitemid 18057782)
71. Coppo R., Mazzucco G., Martina G., Roccatello D., Amore A., Novara R., Bargoni A., Piccoli G., Sena L. M., Gluten-induced experimental IgA glomerulopathy Laboratory Investigation 1989 60 4 499 506 (Pubitemid 19141798)
72. Yan D., Rumbeiha W. K., Pestka J. J., Experimental murine IgA nephropathy following passive administration of vomitoxin-induced IgA monoclonal antibodies Food and Chemical Toxicology 1998 36 12 1095 1106 (Pubitemid 29002892)
73. Pestka J. J., Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions Toxicology Letters 2003 140-141 287 295 (Pubitemid 36378947)
74. Shi Y., Pestka J. J., Attenuation of mycotoxin-induced IgA nephropathy by eicosapentaenoic acid in the mouse: dose response and relation to IL-6 expression Journal of Nutritional Biochemistry 2006 17 10 697 706 (Pubitemid 44380374)
75. Hinoshita F., Suzuki Y., Yokoyama K., Experimental IgA nephropathy induced by a low-dose environmental mycotoxin, nivalenol Nephron 1997 75 4 469 478 (Pubitemid 27156743)
76. Smerud H. K., Fellstrm B., Hllgren R., Osagie S., Venge P., Kristjnsson G., Gastrointestinal sensitivity to soy and milk proteins in patients with IgA nephropathy Clinical Nephrology 2010 74 5 364 371
77. Smith A. C., Molyneux K., Feehally J., Barratt J., O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy Journal of the American Society of Nephrology 2006 17 12 3520 3528 (Pubitemid 44865295)
78. Suzuki H., Suzuki Y., Yamanaka T., Hirose S., Nishimura H., Toei J., Horikoshi S., Tomino Y., Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23 Journal of the American Society of Nephrology 2005 16 5 1289 1299 (Pubitemid 41716513)
79. Akira S., Takeda K., Kaisho T., Toll-like receptors: critical proteins linking innate and acquired immunity Nature Immunology 2001 2 8 675 680 (Pubitemid 32747155)
80. Akira S., Takeda K., Toll-like receptor signalling Nature Reviews Immunology 2004 4 7 499 511 (Pubitemid 38931765)
81. Suzuki H., Suzuki Y., Narita I., Aizawa M., Kihara M., Yamanaka T., Kanou T., Tsukaguchi H., Novak J., Horikoshi S., Tomino Y., Toll-like receptor 9 affects severity of IgA nephropathy Journal of the American Society of Nephrology 2008 19 12 2384 2395
82. Kaisho T., Akira S., Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice Trends in Immunology 2001 22 2 78 83 (Pubitemid 32667525)
83. Ashkar A. A., Rosenthal K. L., Toll-like receptor 9, CpG DNA and innate immunity Current Molecular Medicine 2002 2 6 545 556 (Pubitemid 34982187)
84. Leadbetter E. A., Rifkin I. R., Marshak-Rothstein A., Toll-like receptors and activation of autoreactive B cells Current Directions in Autoimmunity 2003 6 105 122
85. Carter R. H., Myers R., Germinal center structure and function: lessons from CD19 Seminars in Immunology 2008 20 1 43 48
86. Sanderson R. D., Lalor P., Bernfield M., B lymphocytes express and lose syndecan at specific stages of differentiation Cell Regulation 1989 1 1 27 35
87. Aizawa M., Suzuki Y., Suzuki H., Pang H., Kihara M., Yamaji K., Horikoshi S., Tomino Y., Roles of bone marrow, mucosa and lymphoid tissues in pathogenesis of murine IgA nephropathy Contributions to Nephrology 2007 157 164 168
88. Shinkura R., Matsuda F., Sakiyama T., Tsubata T., Hiai H., Paumen M., Miyawaki S., Honjo T., Defects of somatic hypermutation and class switching in alymphoplasia (aly) mutant mice International Immunology 1996 8 7 1067 1075 (Pubitemid 26235710)
89. Masuda Y., Tamura S., Sugiyama N., The effect of tonsillectomy and its postoperative clinical course in IgA nephropathy with chronic tonsillitis Advances in Oto-Rhino-Laryngology 1992 47 203 207
90. Masuda Y., Terazawa K., Kawakami S., Ogura Y., Sugiyama N., Clinical and immunological study of IgA nephropathy before and after tonsillectomy Acta Oto-Laryngologica 1988 106 454, supplement 248 255 (Pubitemid 19017737)
91. Tomioka S., Miyoshi K., Tabata K., Hotta O., Taguma Y., Clinical study of chronic tonsillitis with IgA nephropathy treated by tonsillectomy Acta Oto-Laryngologica 1996 523, supplement 175 177 (Pubitemid 26129376)
92. Sato D., Suzuki Y., Kano T., Tonsillar TLR9 expression and efficacy of tonsillectomy with steroid pulse therapy in IgA nephropathy patients. Nephrology Dialysis Transplantation, 2011. In press
93. Goto T., Bandoh N., Yoshizaki T., Nozawa H., Takahara M., Ueda S., Hayashi T., Harabuchi Y., Increase in B-cell-activation factor (BAFF) and IFN- productions by tonsillar mononuclear cells stimulated with deoxycytidyl- deoxyguanosine oligodeoxynucleotides (CpG-ODN) in patients with IgA nephropathy Clinical Immunology 2008 126 3 260 269
94. Kodama S., Suzuki M., Arita M., Mogi G., Increase in tonsillar germinal centre B-1 cell numbers in IgA nephropathy (IgAN) patients and reduced susceptibility to Fas-mediated apoptosis Clinical and Experimental Immunology 2001 123 2 301 308 (Pubitemid 32174783)
95. Ng L. G., Ng C. H., Woehl B., Sutherland A. P. R., Huo J., Xu S., Mackay F., Lam K. P., BAFF costimulation of Toll-like receptor-activated B-1 cells European Journal of Immunology 2006 36 7 1837 1846 (Pubitemid 44089050)
96. Iio K., Nagasawa Y., Iwatani H., Yamamoto R., Horii A., Okuzaki D., Furumatsu Y., Inohara H., Nojima H., Imai E., Isaka Y., Rakugi H., Microarray analysis of tonsils in immunoglobulin A nephropathy patients Biochemical and Biophysical Research Communications 2010 393 4 565 570
97. Krug A., Towarowski A., Britsch S., Rothenfusser S., Hornung V., Bals R., Giese T., Engelmann H., Endres S., Krieg A. M., Hartmann G., Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with Cd40 ligand to induce high amounts of IL-12 European Journal of Immunology 2001 31 10 3026 3037 (Pubitemid 32994554)
98. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., Akira S., Small-antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nature Immunology 2002 3 2 196 200 (Pubitemid 34141451)
99. Kerkmann M., Rothenfusser S., Hornung V., Towarowski A., Wagner M., Sarris A., Giese T., Endres S., Hartmann G., Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells Journal of Immunology 2003 170 9 4465 4474 (Pubitemid 36519951)